Jennifer good trevi therapeutics
WebMar 17, 2024 · Jennifer Good has been working as a Chief Executive Officer, President & Co-Founder at Trevi Therapeutics for 12 years. Trevi Therapeutics is part of the Business … WebApr 12, 2024 · Trevi Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $6.80. See Insiders’ Hot Stocks on TipRanks >> Based on Trevi …
Jennifer good trevi therapeutics
Did you know?
WebNov 14, 2024 · Trevi Therapeutics, Inc. ( NASDAQ: TRVI) Q3 2024 Earnings Conference Call November 10, 2024 4:30 PM ET Company Participants Jennifer Good - President and CEO Lisa Delfini - CFO Conference... WebFeb 16, 2024 · Jennifer Good is 55, she's been the President, Chief Executive Officer, Co-Founder, and Director of Trevi Therapeutics since 2011. There are 14 older and 4 younger …
WebApr 11, 2024 · NEW HAVEN, Conn., April 11, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis (IPF) and other chronic cough indications, and for the … WebYou will learn tools you can use to effect the change you are seeking and find balance in your life. Call or Email Jennifer Quade for a free phone consultation now - (980) 365-6619.
WebAug 14, 2024 · Trevi Therapeutics, Inc. ( NASDAQ: TRVI) Q2 2024 Earnings Conference Call August 13, 2024 4:30 PM ET Company Participants Jennifer Good - President and CEO Chris Seiter - CFO Conference... WebApr 11, 2024 · Trevi intends to propose Haduvio as the trade name for nalbuphine ER. Its safety and efficacy have not been evaluated by any regulatory authority. For more information, visit www.TreviTherapeutics.com and follow the Company on Twitter and LinkedIn. Investor Contact Katie McManus Trevi Therapeutics, Inc. 203-304-2499 …
WebDec 13, 2024 · The 2024 CURE Entrepreneur of the Year award was presented to Jennifer Good of Trevi Therapeutics and Dr. Vlad Coric of Biohaven Pharmaceuticals. Contacts … giant m\u0026m candyWebJennifer Good is the co-founder of Trevi Therapeutics and serves as a director as well as the Company’s President and Chief Executive Officer. Prior to founding Trevi, Ms. Good … giant mucus plug in noseWebMar 8, 2024 · "We are pleased with this allowance of claims to further secure IP protection for Haduvio through 2039 for the treatment of chronic cough in IPF," said Jennifer Good, President and CEO of... frozen brandy old fashioned slushWebFeb 24, 2024 · Jennifer Good is currently Director, President and Chief Executive Officer at Trevi Therapeutics and Director at Rhythm Pharmaceuticals. Jennifer Good has studied at Pacific Lutheran University. × We use cookies to provide a better service. frozen brats microwave readyWebJul 19, 2024 · Dr. Jennifer Segura, MD, Psychiatrist, Charlotte, NC, 28277, (919) 800-0584, My goal is to provide compassionate, non-judgmental, comprehensive, high quality care … giant mug with coffee pot packs gift setWebJul 14, 2024 · NEW YORK, NY / ACCESSWIRE / July 14, 2024 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with Trevi Therapeutics. Mark Roberts, Senior Editor at Traders News Source had the opportunity to … giant multinucleated cellsWebOct 21, 2024 · “We are pleased with the continued progress of our clinical development programs in these two severe conditions,” said Jennifer L. Good, President and CEO of Trevi Therapeutics. giant mule deer sheds